ADCs have become a core pillar of cancer treatment as increasingly sophisticated design is translating into stronger efficacy ...
- Stipple Bio’s Pointillist Platform identifies tumor-specific cell surface epitopes that, when combined with Lonza’s clinically validated ADC platform, may enable first-in-class and best-in-class ADC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results